.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Accenture
Julphar
Moodys
McKinsey
AstraZeneca
US Department of Justice
Fish and Richardson
Deloitte
McKesson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Physiological Effect: Decreased Prostaglandin Production

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer IngelheimAGGRENOXaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL020884-001Nov 22, 1999ABRXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-001Dec 24, 1997ABRXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-002Dec 24, 1997ABRXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Zydus Pharms Usa IncASPIRIN AND DIPYRIDAMOLEaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL206753-001Aug 29, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Amneal PharmsASPIRIN AND DIPYRIDAMOLEaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL206392-001Mar 8, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Impax Labs IncASPIRIN AND DIPYRIDAMOLEaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL206964-001Jan 18, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Par Pharm IncASPIRIN AND DIPYRIDAMOLEaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL207944-001Jan 18, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Watson LabsBUTALBITAL, ASPIRIN AND CAFFEINEaspirin; butalbital; caffeineCAPSULE;ORAL086231-002Feb 12, 1985DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
PiiBUTALBITAL, ASPIRIN AND CAFFEINEaspirin; butalbital; caffeineTABLET;ORAL204195-001Sep 22, 2016AARXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Hikma Intl PharmsBUTALBITAL, ASPIRIN AND CAFFEINEaspirin; butalbital; caffeineTABLET;ORAL086162-002Feb 16, 1984AARXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Deloitte
Mallinckrodt
QuintilesIMS
McKinsey
Boehringer Ingelheim
Cerilliant
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot